Jiangsu Hengrui Medicine Co., Ltd.
Status: Publicly traded
Direct answer
Jiangsu Hengrui Medicine Co., Ltd. is publicly traded on SHH under the ticker 600276.SS.
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459,...
Can you invest in Jiangsu Hengrui Medicine Co., Ltd.?
Yes. Jiangsu Hengrui Medicine Co., Ltd. is publicly traded on SHH under the ticker 600276.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jiangsu Hengrui Medicine Co., Ltd.
Detailed equity research is provided by MarketSnap.